Aspect Biosystems


Tamer Mohamed, President and CEO 

April 9 | 9:45am | Salone dei Cavalieri, Section 2

Vancouver, Canada 


Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body. The company’s current therapeutic pipeline is focused on metabolic and endocrine diseases such as diabetes, obesity, and congenital liver disorders.

By using this website you agree to accept our Privacy Policy and Terms & Conditions